Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ethinyl Estradiol; Etonogestrel Patent Expiration

Ethinyl Estradiol; Etonogestrel was first introduced by Organon Usa Llc A Sub Of Organon And Co in its drug Nuvaring on Oct 3, 2001. 5 different companies have introduced drugs containing Ethinyl Estradiol; Etonogestrel.


Ethinyl Estradiol; Etonogestrel Patents

Given below is the list of patents protecting Ethinyl Estradiol; Etonogestrel, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Nuvaring US5989581 Drug delivery system for two or more active substances Apr 08, 2018

(Expired)

 Organon Usa Organon



Ethinyl Estradiol; Etonogestrel's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ethinyl Estradiol; Etonogestrel Generic API Manufacturers

Several generic applications have been filed for Ethinyl Estradiol; Etonogestrel. The first generic version for Ethinyl Estradiol; Etonogestrel was by Amneal Pharmaceuticals Llc and was approved on Dec 11, 2019. And the latest generic version is by Xiromed Pharma Espana Sl and was approved on Jun 29, 2023.

Given below is the list of companies who have filed for Ethinyl Estradiol; Etonogestrel generic, along with the locations of their manufacturing plants worldwide.